M. R. C. Clinical Pharmacology Research group, Department of Clinical Pharmacology, Royal Postgraduate Medical School, London.
Br J Clin Pharmacol. 1974 Apr;1(2):129-36. doi: 10.1111/j.1365-2125.1974.tb00221.x.
1 The metabolism of terbutaline (1-(3,5-dihydroxyphenyl)-2-tertiarybutylamino-ethanol), a drug which acts selectively on β(2)-adrenoceptors has been studied in man and dog. 2 The sulphate conjugate of terbutaline was the only metabolite identified in plasma or urine from humans or dogs given the drug either orally or intravenously. We have confirmed that terbutaline, a resorcinol derivative, is not a substrate for catechol-0-methyl transferase in man or dog. 3 Metabolism of terbutaline was dependent upon the route of administration in man, but not in dog. In man, oral terbutaline was largely conjugated whereas drug administered intravenously appeared largely unchanged in urine. 4 Conjugation of oral terbutaline, which probably occurred during the `first-pass' through the gut wall or liver, was less than oral isoprenaline. This may explain why the poorly absorbed terbutaline is a more effective oral bronchodilator than isoprenaline, even though the latter drug is completely absorbed following oral dosing.
特布他林(1-(3,5-二羟基苯基)-2-叔丁基氨基-乙醇)的代谢作用,一种选择性作用于β(2)-肾上腺素能受体的药物,已经在人和狗中进行了研究。
给人或狗口服或静脉内给予特布他林后,在血浆或尿中仅鉴定出特布他林的硫酸盐缀合物为代谢物。我们已经证实,特布他林,间苯二酚衍生物,不是人或狗儿茶酚-O-甲基转移酶的底物。
特布他林的代谢作用取决于在人中的给药途径,但在狗中则不是。在人中,口服特布他林主要是结合的,而静脉内给予的药物在尿中则几乎没有变化。
口服特布他林的结合作用(可能发生在“首过”通过肠壁或肝脏期间)小于口服异丙肾上腺素。这可能解释了为什么吸收不良的特布他林是一种比异丙肾上腺素更有效的口服支气管扩张剂,尽管后者药物在口服给药后完全被吸收。